Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with...
Day: October 10, 2025
OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance
Company to host conference call today, October 9th, 2025, to discuss the financial results and updated outlookWARSAW, Ind., Oct. 09,...
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease...
Procedure of the Annual General Meeting
ANNOUNCEMENT NO. 294 9 October 2025 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was...
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical...
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics...
Executive Wellness Retreats: Grey Matters International Announces Expansion of Neuroscience-Based Programs
Discover a neuroscience-based path to better mental health and executive well-being with Grey Matters International. Their personalized retreats combine brain...
Academy Award-Winning Actress Helen Hunt to Headline Methodist Healthcare Foundation Luncheon
Memphis, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- The Methodist Healthcare Foundation will welcome Academy Award-winning actress and breast cancer...
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has...
Childhood Cancer Deserves Year-Round Commitment to Funding and Research
Mothers channel loss into a $1.5 million commitment to fund childhood cancer research.HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Five...
JOURTHON® Launches Brain Health Softgel
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Memory lapses, poor concentration, and mental fatigue are no longer just signs...
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory...
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025 (Pursuant to Article L.233-8 II of the...
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
Announcement no. 09/2025Inside information Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting ...
Idorsia launches an offering of registered shares – to fund the company to overall profitability
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY,...
ICPO Foundation welcomes 24 new ICPO Theranostics Clinical Centers of Excellence to its global network of 45 centers
ICPO Center Certification Ceremony with 24 new ICPO Theranostics Clinical Center of Excellence in Barcelona on the occasion of the...
CERTIFIED Opens First Columbus Dispensary, Revives Local Landmark with Drive-Thru Cannabis Experience
Ohio-born cannabis brand brings personal story, community focus, and premium products to Silver Drive locationCOLUMBUS, Ohio, Oct. 09, 2025 (GLOBE...
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse modelsCAMBRIDGE, Mass., Oct. 09,...
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando
Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina Subspecialty DayCAMBRIDGE,...
Applications Now Open for Fall 2025 First Practice Fund Scholarship
ST. LOUIS and HINTON, West Virginia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- PracticeLink, the nation’s most trusted physician recruitment resource...